Navigation Links
Venaxis Advances Pivotal U.S. Study and Accelerates European Market Development for APPY1 Blood-based Appendicitis Test
Date:3/26/2013

CASTLE ROCK, Colo., March 26, 2013 /PRNewswire/ -- Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance and commercializing its rapid, protein biomarker-based appendicitis test, APPY1, today provided an update on its clinical and commercial activities.  The Company continues to enroll patients into its ongoing pivotal U.S. clinical study of APPY1, as well as make strong progress on its European market development initiatives.

Steve Lundy , Chief Executive Officer of Venaxis, commented, "We identified a number of significant milestones for 2013 and during the recent months have begun achieving them, including initiation of our pivotal study for APPY1, which we anticipate, upon completion, will support filing for regulatory clearance with the FDA.  We also obtained CE Marking for APPY1, and we commenced an initial launch of the product for market development purposes in Europe.  As we expected, 2013 has been characterized so far by continued progress on these critical initiatives.  We are encouraged by our successful execution to date and we plan to remain focused and diligent so that we can reach the important milestones to come." 

Enrollment into the APPY1 pivotal U.S. clinical study is expected to continue across the 28 participating hospital sites throughout much of 2013.  Based on current projections, the Company anticipates completing the study and potentially filing with the FDA for regulatory clearance of APPY1 by year end 2013. 

Following CE Marking of APPY1 in January, Venaxis successfully executed market development agreements with MOSS S.p.A., which is based near Milan, to cover Italy'/>"/>

SOURCE Venaxis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AspenBio Pharma Changes Company Name to Venaxis, Inc.
2. Venaxis to Present at 2013 BIO CEO and Investor Conference
3. Venaxis Presentation Rescheduled for 2013 BIO CEO and Investor Conference
4. Venaxis to Present at 25th Annual ROTH Conference
5. Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease
6. Selexis Lubris Partnership Advances Difficult-to-Express Protein Towards Clinic
7. Medical Imaging Information Systems Market to 2017 - Replacement of Legacy Systems and Advances in Software Present Growth Opportunities
8. Ampio Advances NCE001 Cancer Drug into Preclinical Development Following Successful Recent Financing and the Granting of Patents in USA, Canada, Europe and China
9. URAC sets standards for community pharmacy, advances dialogue about pharmacists as medication experts
10. Neurostimulation Devices Market to 2018 - Technological Advances and Robust Pipeline with Multi-Indication Potential and Non-Invasive Therapies to Drive Growth
11. Pharmaceutical Supply Chain in the US - Advances in RFID and ePedigree Systems to Limit Drug Counterfeits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Germany , July 30, 2014  invendo ... and computer-assisted ("robotic") colonoscopy system, today announced the appointment ... medical device executive, as a new member of its ... highly respected global visionary in the medical device industry. ... and Chief Executive Officer at Given Imaging Ltd. (NASDAQ/TASE: ...
(Date:7/30/2014)... and PARIS , July 30, 2014 ... and Sanofi (EURONEXT: SAN and NYSE: SNY ... trials of alirocumab in people with hypercholesterolemia met their ... baseline in low-density lipoprotein cholesterol (LDL-C) at 24 weeks ... investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type ...
(Date:7/30/2014)... , July 30, 2014  DigiPath, Inc. (OTCBB ... is expanding into the cannabis testing and education markets, ... its business and affairs not previously disclosed or, to ... recent unusual market action. "We have noticed ... the last three trading days," said Steve Barbee ...
Breaking Medicine Technology:invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8DigiPath No New Corporate Developments 2
... Jan. 5, 2012  Isis Pharmaceuticals, Inc. (NASDAQ: ... Phase 1 study with ISIS-TTRRx.  The results demonstrated ... reductions of greater than 80 percent in transthyretin ... well tolerated with no significant adverse events.  ISIS-TTRRx ...
... (NASDAQ: AMRI ), a global contract services ... preferred provider agreement with BioPontis Alliance LLC. The agreement ... gap between early-stage research and technologies being discovered and ... provide its services in small molecule discovery, development, and ...
Cached Medicine Technology:ISIS Reports Phase 1 Data Demonstrating ISIS-TTRRx Produces Significant Reductions in TTR Protein 2ISIS Reports Phase 1 Data Demonstrating ISIS-TTRRx Produces Significant Reductions in TTR Protein 3ISIS Reports Phase 1 Data Demonstrating ISIS-TTRRx Produces Significant Reductions in TTR Protein 4AMRI Announces Preferred Provider Agreement with BioPontis Alliance LLC 2AMRI Announces Preferred Provider Agreement with BioPontis Alliance LLC 3
(Date:7/30/2014)... 30, 2014 Daily Gossip indicates in its ... easily. A panic attack is a feeling of intense stress ... are a series of symptoms that sufferers commonly deal with ... of breath, stress or anxiety. Naturally, panic attacks deeply affect ... way to overcome them. , The 60 Second Panic Solution ...
(Date:7/30/2014)... The Restore My Blood Sugar review recently ... sugar levels can now find an amazingly successful method of ... was created by D. Chao and Andrew Forester who claim ... when it comes to normalizing blood sugar levels. Chao actually ... secret to the cure of diabetes that all patients should ...
(Date:7/30/2014)... 30, 2014 Within weeks freshman will begin to ... Each hopes this will be a time of growth and the ... to pause; it may not be as easy as it looks. ... will switch their major at least once and many will switch ... and the costs are exacerbated when switching in the later years ...
(Date:7/30/2014)... July 30, 2014 Ticket Down ... Bayern Munich vs. Chivas Guadalajara friendly exhibition match at ... World Cup, the one team that was left standing as ... made it through the world’s largest football competition and even ... their way to the cup. Germany was led by seven ...
(Date:7/30/2014)... HealthDay Reporter WEDNESDAY, July 30, 2014 ... to develop dementia, but researchers have been unable to explain ... Specifically, they haven,t been able to figure out the direction ... on dementia, or does dementia cause people to become depressed? ... journal Neurology sheds more light on the mystery. ...
Breaking Medicine News(10 mins):Health News:60 Second Panic Solution Review Reveals Unique Way to Stop Panic Attacks 2Health News:Restore My Blood Sugar Review Reveals Exclusive Ways to Normalize Blood Sugar 2Health News:Advice to College Freshman from Author Garrett Miller 2Health News:Advice to College Freshman from Author Garrett Miller 3Health News:Bayern Munich vs. Chivas Guadalajara Tickets Red Bull Arena: Ticket Down Slashes Ticket Prices for Chivas Guadalajara vs. Bayern Munich in Harrison, NJ 2Health News:Bayern Munich vs. Chivas Guadalajara Tickets Red Bull Arena: Ticket Down Slashes Ticket Prices for Chivas Guadalajara vs. Bayern Munich in Harrison, NJ 3Health News:Scientists Shed Light on Link Between Depression, Dementia 2Health News:Scientists Shed Light on Link Between Depression, Dementia 3
... 16 A grassroots,effort to promote advance care planning ... than 450 participating organizations in,all 50 states. The first ... a year ago and implemented with no budget or,full-time ... am blown away by the response to our grassroots ...
... know anyone,who,s a Type-A personality? A multi-tasking, go-getter? ... would turn out to be Type-A.,There,s a lot ... But the antioxidants,deserve some special attention., (Photo: ... food by their deep-colored pigment - such as ...
... thinking skills, study finds , , WEDNESDAY, April 16 (HealthDay News) ... than women to develop mild cognitive impairment, new research shows. ... found more women than men [or an equal proportion] have ... men," study author Rosebud Roberts, of the Mayo Clinic in ...
... Abstract 19, Study highlights:, -- Low ... prevalence,of peripheral arterial disease (PAD) in a study that ... feel this needs further study and do not recommend,people ... by,their doctors., -- The American Heart Association recommends ...
... patient care while ... saving Medicaid dollars, ... Best Practices in Consumer Empowerment and,Protection Awards competition, naming the ... Eli Lilly,and Company as Silver Award winners in the Health ...
... Challenges Facing the ... Healthcare Industry, ... association with U.S. News & World Report,hosted an exclusive panel ... the National Press Club in Washington, D.C.,The event, attended by ...
Cached Medicine News:Health News:More Than 350 Events Today in Recognition of First National Healthcare Decisions Day 2Health News:Cranberries: The Little Fruit With a Great Big Punch 2Health News:Cranberries: The Little Fruit With a Great Big Punch 3Health News:Low Vitamin D Levels Associated With an Increased Risk of Peripheral Arterial Disease 2Health News:Low Vitamin D Levels Associated With an Increased Risk of Peripheral Arterial Disease 3Health News:Mental Health Prescription Program Named Winner in URAC's Best Practices in Consumer Empowerment and Protection Awards 2Health News:Mental Health Prescription Program Named Winner in URAC's Best Practices in Consumer Empowerment and Protection Awards 3Health News:Mental Health Prescription Program Named Winner in URAC's Best Practices in Consumer Empowerment and Protection Awards 4Health News:Siemens Addresses Cost vs. Value Issues In Healthcare and Technology 2Health News:Siemens Addresses Cost vs. Value Issues In Healthcare and Technology 3
... Lubri-Flex Open Tip Ureteral Stents combine ... body temperature while remembering its shape with ... ultra-slippery when moistened. The result is a ... of placement and patient comfort. Lubri-Flex® is ...
... The Pathfinder Chlamydia Culture ... reliable staining of intracellular ... reticulate bodies) in tissue ... antibody used in this ...
... Pathfinder RSV EIA Kit is a direct antigen ... aspirates. It uses polyclonal and monoclonal antibodies ... This assay combines the specificity and reproducibility of ... an EIA. Qualitative results are availalbe within ...
The autoclavable, aluminum needle box is designed to store loaded needles and help protect personnel from exposure. Each shield consists of an aluminum box with faceplate to match the grid pattern th...
Medicine Products: